POLY MEDICURE LIMITED (POLYMED)

NSE: ₹1,405.00
BSE: ₹1,406.40
Stock Performance
Corporate Announcements
2026-06-12 16:42:20
2026-06-10 14:57:49
Intimation Of Analyst/Investor Meet

The Company informed about the Analyst/Investor Meet to be held on 08th June, 2026.

2026-06-03 17:19:13
2026-06-02 17:48:43
Announcement under Regulation 30 (LODR)-Change in Management

The Company informed the appointment of Mr. Indranil Mukherjee as Chief Executive Officer - Asia Pacific and India Business, Senior Management Personnel(SMP) of the Company

2026-06-01 18:58:10
Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report for the year ended 31st March, 2026

2026-05-26 15:09:51

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 320.83 337.29 339.60 378.07 384.78 420.02 424.21 440.83 403.21 443.88 493.66 534.51
YOY Revenue Growth % 28.92% 22.79% 19.23% 23.21% 19.93% 24.52% 24.92% 16.6% 4.79% 5.68% 16.37% 21.25%
Other Income 13.11 14.09 16.57 14.97 16.92 26.10 21.80 24.31 41.69 33.94 26.26 17.76
Total Income 333.94 351.39 356.17 393.05 401.70 446.11 446.01 465.14 444.90 477.83 519.92 552.27
Total Expenses + 251.65 271.27 269.05 300.82 303.67 328.88 334.51 344.56 323.28 357.10 417.19 468.75
Cost of Materials Consumed 105.25 114.21 118.72 126.61 132.57 154.88 141.95 141.95 141.07 157.07 146.17 155.08
Employee Benefit Expense 57.75 58.32 60.40 69.44 70.79 78.09 77.89 78.89 75.11 88.83 115.20 126.14
Other Expenses 63.74 73.54 70.93 80.85 81.81 94.08 85.26 95.08 94.73 104.71 111.51 119.81
Operating Profit 69.18 66.02 70.54 77.25 81.10 91.13 89.71 96.26 79.93 86.78 76.47 65.76
OPM % 21.6% 19.6% 20.8% 20.4% 21.1% 21.7% 21.1% 21.8% 19.8% 19.6% 15.5% 12.3%
Profit Before Tax + 83.04 80.11 87.11 92.23 98.02 117.23 111.51 120.57 121.62 120.73 95.93 83.51
Tax Expense 20.35 17.92 22.10 23.87 23.98 29.78 26.28 28.74 28.54 28.93 25.12 18.47
Tax % 24.5% 22.4% 25.4% 25.9% 24.5% 25.4% 23.6% 23.8% 23.5% 24% 26.2% 22.1%
Profit After Tax 62.70 62.19 65.02 68.36 74.04 87.45 85.23 91.83 93.08 91.80 70.81 65.04
EPS (Basic) 6.54 6.48 6.78 7.12 7.71 9.01 8.48 8.92 9.19 9.06 7.00 6.54

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 1,875.26 1,669.83 1,375.80 1,115.23 923.06 786.47 687.24
YOY Revenue Growth % 12.3% 21.37% 23.36% 20.82% 17.37% 14.44% -
Other Income 120.08 89.13 58.75 36.19 37.90 18.42 18.46
Total Income 1,995.34 1,758.96 1,434.54 1,151.42 960.97 804.88 705.70
Total Expenses + 1,566.75 1,311.62 1,092.80 915.85 768.17 628.14 531.45
Cost of Materials Consumed 599.39 571.36 464.78 424.31 352.37 266.58 225.22
Employee Benefit Expense 402.26 301.53 245.91 202.75 163.62 141.76 138.76
Other Expenses 433.88 360.77 289.06 241.22 198.27 168.49 167.47
Operating Profit 308.51 358.21 282.99 199.38 154.90 158.33 155.79
OPM % 16.5% 21.5% 20.6% 17.9% 16.8% 20.1% 22.7%
Profit Before Exceptional 428.59 447.34 341.74 235.56 192.80 176.74 123.58
Exceptional Items -6.80 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 421.79 447.34 341.74 235.56 192.80 176.74 123.58
Tax Expense 101.06 108.78 83.48 56.28 46.29 40.87 27.70
Tax % 24% 24.3% 24.4% 23.9% 24% 23.1% 22.4%
Profit After Tax 320.73 338.56 258.26 179.28 146.51 135.87 95.88
EPS (Basic) 31.79 34.13 26.92 18.69 15.28 15.25 10.86

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 1,976.83 1,275.46 1,017.05 770.20 593.40 517.95 0.00
Property, Plant & Equipment 1,255.15 1,038.14 818.53 587.32 438.68 374.11 0.00
Capital Work in Progress 90.51 89.65 66.70 72.58 37.14 14.74 0.00
Non-Current Investments 0.61 7.28 20.44 0.00 0.00 0.00 0.00
Goodwill 273.79 28.58 28.58 28.58 28.58 28.58 0.00
Other Intangible Assets 157.09 15.19 15.99 15.97 15.81 16.36 0.00
Current Assets + 1,941.73 1,917.00 841.63 807.01 783.44 705.78 0.00
Inventories 433.84 285.57 221.03 208.65 168.36 126.48 0.00
Trade Receivables 531.17 349.73 269.94 235.43 206.63 156.50 0.00
Cash and Cash Equivalents 51.23 8.70 12.05 7.06 7.76 4.95 0.00
Current Investments 739.16 1,000.00 139.54 118.59 336.60 345.01 0.00
LIABILITIES & EQUITY
Total Equity 3,149.24 2,765.66 1,470.05 1,241.63 1,087.48 965.57 0.00
Equity Share Capital 50.68 50.66 47.99 47.97 47.95 47.94 0.00
Other Equity 3,055.49 2,715.00 1,422.07 1,193.65 1,039.53 917.63 0.00
Non-Current Liabilities 193.80 56.63 37.38 42.28 62.68 86.76 0.00
Current Liabilities 575.52 370.17 351.24 293.30 226.68 171.40 0.00
Total Liabilities 769.32 426.79 388.62 335.58 289.35 258.16 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 240.69 241.09 266.08 190.83 123.47 118.73 0.00
Cash from Investing Activities -225.38 -1,191.17 -240.94 -179.02 -85.33 -435.58 0.00
Cash from Financing Activities 20.15 952.93 -20.15 -12.51 -35.34 316.95 0.00
Net Increase/Decrease in Cash 36.85 2.85 4.99 -0.69 2.80 0.10 0.00